对晚期缺血性心肌病患者的程序性方法:将微轴支持集成到现代时代的策略中
Jean-Luc A Maigrot1, Aaron J Weiss1, Michael Z Y Tong1
1Department of Thoracic and Cardiovascular Surgery, Kaufman Center for Heart Failure and Recovery, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Artificial organs
|November 28, 2023
概括
管理晚期缺血性心肌病需要仔细评估风险,以获得最佳治疗. 本综述详细介绍了识别高风险患者和个性化治疗策略,以改善结果.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭研究研究
- 临床医学 临床医学
背景情况:
- 先进的缺血性心肌病症呈现出不同严重程度的左心室功能障碍.
- 治疗决策是复杂的,涉及医疗疗法,再血管化,机械支持和移植.
- 低于最佳的结果可能是由于误判患者的风险和选择不合适的治疗方法.
研究的目的:
- 为评估和优化患有缺血性心肌病的高风险患者概述一个程序化的方法.
- 提出治疗决策策略,以提高患者的治疗结果.
- 确定管理复杂心脏病的关键因素.
主要方法:
- 对缺血性心肌病的当前治疗途径的审查.
- 讨论患者鉴定和风险分层协议.
- 对外科优化决策策略的分析.
主要成果:
- 高风险患者需要量身定制的治疗计划.
- 结构化的评估和优化过程至关重要.
- 个性化治疗策略可以改善短期和长期的结果.
结论:
- 缺血性心肌病的有效管理取决于准确的风险评估和个性化治疗.
- 程序式方法提高了患者的护理和结果.
- 优化治疗决策是改善晚期心脏病患者预后的关键.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...


